Lead EHS & Security manager at secondary aseptic manufacturing vaccine facility, responsible for budget of $1.7 million and management of > 20 personnel, including both GSK employees and contractors. Risk Team Leader for identification and management of EHS&S risks. Accountable for FM Global and US Department of Homeland Security recommendations. • Transformed EHS&S program from legacy skeleton framework to robust EHS&S Management System in alignment with GSK international standards.• Managed transition of proprietary security staff to outsourced contract, resulting in improved quality of service as well as cost saving. • Organized EHS&S department including recruitment of Occupational Nurse, Certified Safety Professional, Security Manager & Compliance Specialist, and management of Environmental Specialist and Safety Specialist. Included clear objectives, opportunities for development, and accountability. • Introduced innovative programs to manage critical risks, including Permit to Work, LockOutTagOut, Confined Space, Contractor Safety, Machine Guarding, and Ergonomics.• Managed permit modification with PA Department of Environmental Protection to allow for large scale infectious waste processing for live virus.• Managed FM Global recommendations, resulting in increase in 'GSK Mark' score from 70% to 100%.

Global responsibility: BMS biosafety/biotechnology and potent compound containment. Provide technical guidance, expert advice, and program support to all BMS affected businesses worldwide. Provide EHS coordination to support BMS biologic initiatives for engineering projects, in-licensing, acquisitions, manufacturing launch, and MSDS writing. • Developed strategy for EHS in new BioPharm model, including a FTE model for site biosafety support, plan for ethical review of use of human stem cells, new MSDS template for biologic compounds, and containment model for biologics based on industrial hygiene monitoring data for Orencia. • Led EHS & Medical Due Diligence and Alignment Team for integration of Adnexus. Coordinated transfer of necessary permits prior to closing and developed transition plan. While working in an ambiguous environment, developed priorities, and provided direction for Adnexus staff to meet regulatory compliance and BMS standards. When necessary, elevated issues of critical risk to appropriate management. Received BMS R&D Galaxy and Star Awards. • Organized and led large cross-functional team to revise BMS Lab Containment Guidelines, resulting in a risk based model for the containment of potent pharmaceutical compounds in laboratories resulting in a product which ensures worker protection while reducing ventilation costs. Received Corporate Award of Distinction. • Provided biosafety support for R&D sites, including development of OneBMS Institutional Biosafety Committee, developed four training modules for viral vectors, and writing of charter template for BMS IBCs for structure in lieu of NIH Guidelines. • Led team to develop new Enterprise-wide program for Biological Assessment of Risk (BAR). Developed BAR Information Management (IM) business process, and provided direction to IM project manager and biosafety team for requirements gathering. • Provided EHS coordination for the EHS requirements for Devens and Biocon engineering design teams.

Developed and implemented comprehensive safety management programs for major BMS R&D site, including Biosafety, Chemical Hygiene, Reproductive Health, Indoor Air Quality, Respiratory Protection. • Led BMS Regional Lab Ventilation Team, resulting in strategic harmonized SOP for management of laboratory containment devices across several R&D sites. Received Corporate Award of Distinction. • Chaired HPW EHS Steering Committee, resulting in alignment of safety programs for laboratory research departments. • Received Corporate Award of Distinction for EHS Biotechnology Assessment Program.

Developed and implemented a comprehensive safety management program for the New Brunswick campus of UMDNJ. Responsibilities include laboratory safety, indoor air investigations, spill control and emergency response, training development and delivery. • Developed chemical safety training modules for lab safety on EOHSS website. • Developed procedure for review of human gene transfer protocols. • Developed Biosafety guidelines for clinical trials involving viral vectors.

Snohomish County lies north of Seattle with a population of 525,000 and covers 2,090 square miles. Responsibilities included program development and presentation of training programs, grant writing, newsletter publication, investigation of infectious disease outbreaks, inspection and enforcement of Food Code for major retail food chains. Snohomish Health District won the National 1997 Crumbine Award for Consumer Protection. • Developed “Partners in Childcare” Health & Safety program to assess and intervene with environmental health problems in childcare, resulting in a model program in Washington State for health consultation and was nominated for innovation award from National Association of City and County Health Organizations. • Appointed Chair of Washington State Health and Safety Subcommittee for 3 years.